Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Telogen effluvium is hair loss caused by disruption of the normal hair cycle.

A girl lost her hair due to being given the wrong medication because of a pharmacy's computer error.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Glass ceiling syndrome is linked to stress-related hair loss in female healthcare workers.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

The marine protein complex, Viviscal®, was found to effectively reduce hair loss and improve hair, skin, and nails quality in women.

Heavy metals might contribute to hair loss in Telogen Effluvium.

People with Telogen Effluvium have lower vitamin D levels.

People with telogen effluvium often have much lower vitamin D levels than healthy individuals.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

UV rays can cause a type of hair loss known as telogen alopecia.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Certain growth factors significantly affect hair loss in women with telogen effluvium.

Iontophoresis with growth factors safely and effectively promotes hair regrowth without discomfort.

Hair loss in a child was an early sign of Crohn's disease.

Hair loss can be an early sign of Crohn's disease in children.

The document concludes that a new treatment for a type of hair loss called telogen effluvium was tested and shows promise.

A thorough assessment and combined treatment are crucial for managing complex alopecia, especially in patients with skin of color.

Telogen Effluvium causes increased hair shedding and can be challenging to diagnose and treat.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

The supplement with amino acids, iron, selenium, and marine hydrolyzed collagen improved hair growth more than drug treatment alone, with most people tolerating it well.

Trichoscopy effectively differentiates Androgenetic Alopecia from Telogen Effluvium.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

A woman survived a massive lithium overdose that caused a form of hair loss.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

Systemic diseases can cause hair loss, which is often reversible with treatment.